U.S. Industrial REITs Stock News

NYSE:MH
NYSE:MHConsumer Services

McGraw Hill Data Breach Adds Pressure To Discounted Share Price

McGraw Hill (NYSE:MH) has reported a major data breach alongside an extortion threat targeting its systems and sensitive information. The incident has coincided with a broad selloff across education and training stocks, putting added pressure on the company. Investors are focusing on potential fallout for customer trust, regulatory scrutiny and the company’s operational resilience. The data breach and extortion threat come at a time when McGraw Hill’s share price is already under pressure,...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

TMC The Metals Moves Toward Commercial Seafloor Production With Allseas Deal

TMC the metals (NasdaqGS:TMC) has signed a commercial agreement with Allseas to develop, commission and operate an offshore polymetallic nodule collection system. The system will operate in the Clarion Clipperton Zone and targets a production capacity of 3 million wet tonnes per year. Commissioning of what is expected to be the first large scale nodule recovery system is scheduled to begin in late 2027. TMC the metals is moving from a focus on permitting to building commercial...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Slump

For investors wondering whether Enovis stock is starting to look like value or just looks cheap for a reason, this article walks through the key numbers so you can judge the price for yourself. After a recent 6.2% gain over the past week and a 1.5% rise over the past month, the stock still sits lower for the year to date, with a decline of 6.5%, and is down 32.2% over the past year, 56.7% over three years, and 67.3% over five years. Recent coverage has focused on how Enovis fits within the...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics Phase 3 Lung Data Could Reshape Pulmonary Franchise Outlook

United Therapeutics (NasdaqGS:UTHR) plans to present new phase 3 clinical data for Tyvaso (inhaled treprostinil for idiopathic pulmonary fibrosis) and ralinepag (for pulmonary arterial hypertension) at the upcoming American Thoracic Society International Conference. The company will also share additional research across multiple lung diseases, highlighting a broad set of respiratory-focused findings at the meeting. United Therapeutics focuses on therapies for serious pulmonary and...
NYSE:ABR
NYSE:ABRMortgage REITs

Arbor Realty Trust Resets Dividend As Asset Cleanup And 2027 Outlook Loom

Arbor Realty Trust (NYSE:ABR) has reset its quarterly dividend as part of a broader push to reduce nonperforming assets and real estate owned. Management is emphasizing faster resolution of troubled loans and a lower REO balance, alongside a growing origination pipeline. The company has highlighted plans that target improved asset quality and earnings in late 2026 and 2027. For income focused investors watching NYSE:ABR, the dividend reset comes after a tough stretch for the stock, with...
NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

Is It Too Late To Consider Marvell Technology (MRVL) After Its 165% One-Year Rally?

If you are wondering whether Marvell Technology at US$170.84 is priced for perfection or still offers value, the next sections will help you frame that question clearly. The stock has delivered returns of 4.4% over the past week, 33.0% over the last month, 91.1% year to date and 165.6% over the last year, with 3-year and 5-year returns of 310.2% and 306.9% respectively. Recent coverage has focused on Marvell's positioning within the semiconductor sector and how investors are reacting to its...
NasdaqGM:AGNT
NasdaqGM:AGNTReal Estate

AGNT Rebrands eXp With NextHome Acquisition And Multi Model Upside

eXp World Holdings, now trading under the ticker NasdaqGM:AGNT, has acquired franchise based brokerage NextHome. The company is shifting to a multi model real estate platform that offers both cloud brokerage and franchise options for agents and brokers. The new structure brings multiple brands under one global umbrella, with the AGNT ticker reflecting the broader platform focus. For real estate investors, NasdaqGM:AGNT now represents more than a pure cloud brokerage business. The...
NYSE:PHIN
NYSE:PHINAuto Components

PHINIA (PHIN) Is Up 8.1% After Debuting Hydrogen Van And Boosting Capital Returns - Has The Bull Case Changed?

In early May 2026, PHINIA Inc. showcased its first homologated hydrogen internal combustion engine light commercial vehicle at ACT Expo in Las Vegas, highlighting lower-carbon technology developed with Aramco that meets Euro 7 standards and targets very large reductions in tailpipe CO2 emissions versus diesel. The company coupled this technology milestone with a solid first-quarter earnings report, higher year-on-year sales and net income, continued 2026 guidance, and completion of a...
NasdaqGS:HEPS
NasdaqGS:HEPSMultiline Retail

A Look At Hepsiburada (HEPS) Valuation After Growth-Focused Earnings And Wider Net Loss

D-Market Elektronik Hizmetler ve Ticaret (HEPS) is back on investors’ radar after reporting first quarter 2026 results, with higher sales and gross merchandise value alongside a wider net loss driven by growth investments. See our latest analysis for D-Market Elektronik Hizmetler ve Ticaret. The earnings release appears to have cooled very short term sentiment, with the share price down 2.48% over the last day and 1.43% over the week. However, a 7.42% year to date share price return contrasts...
NYSE:WLK
NYSE:WLKChemicals

Westlake (WLK) Valuation Check As Shares Rebound After Recent Pullback

Why Westlake Stock Is Drawing Attention Now Westlake (WLK) is back on investors’ radar after recent share price swings, with the stock up about 4% over the past day but down roughly 18% over the past month. See our latest analysis for Westlake. The recent 1-day share price return of 3.95% comes after a tougher stretch, with the 30-day share price return down 17.58% even as the year-to-date share price return is 31.57% and the 1-year total shareholder return is 16.98%. This points to fading...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Assessing Oruka Therapeutics (ORKA) Valuation After Equity Raise Collaboration Deal And Trial Updates

Oruka Therapeutics (ORKA) stock is drawing attention after a recently completed $700 million common stock offering raised dilution concerns and coincided with volatility around its Halozyme Hypercon collaboration and interim clinical trial updates. See our latest analysis for Oruka Therapeutics. At a latest share price of US$65.68, Oruka’s recent common stock offering, Halozyme Hypercon agreement and interim trial readouts have gone hand in hand with sharp swings, including a 99.76% 3 month...
NYSE:HESM
NYSE:HESMOil and Gas

Assessing Hess Midstream (HESM) Valuation After Strong Q1 2026 Results And Reaffirmed Guidance

Hess Midstream (HESM) reported first quarter 2026 results that showed higher revenue and net income versus the prior year, while also reaffirming full year earnings and operating guidance, a combination many income focused investors watch closely. See our latest analysis for Hess Midstream. Hess Midstream’s recent earnings announcement comes after a steady share price move, with the stock up 13.10% on a year to date share price basis and a 5 year total shareholder return of 140.87%. This...
NYSE:D
NYSE:DIntegrated Utilities

How Investors Are Reacting To Dominion Energy (D) Earnings Beat, Dividend Payout And New Debt Program

Dominion Energy’s recent quarterly update showed first-quarter 2026 sales rising to US$5,019 million while net income eased to US$621 million, alongside a confirmed quarterly dividend of US$0.6675 per share and a new US$3.00 billion shelf registration for floating rate demand notes with a dividend reinvestment plan. The company’s stronger-than-expected profit and revenue, reaffirmed earnings outlook, and rejection of shareholder proposals on governance and ESG-linked pay together highlight...
NYSE:GWW
NYSE:GWWTrade Distributors

W.W. Grainger (GWW) Is Up 7.4% After Raising 2026 Guidance And Boosting Dividend - What's Changed

In early May 2026, W.W. Grainger reported first-quarter 2026 results showing higher sales of US$4.74 billion and increased net income of US$555 million year over year, raised its full-year 2026 net sales and EPS guidance, and filed a new shelf registration for debt securities. Alongside these results, the company also announced a higher quarterly dividend of US$2.49 per share, extending its multidecade pattern of annual dividend increases and underlining management’s confidence in cash...
NasdaqGS:PNTG
NasdaqGS:PNTGHealthcare

Pennant Group (PNTG) Is Up 9.7% After Q1 2026 Beat And Senior Living Expansion - Has The Bull Case Changed?

The Pennant Group, Inc. has already reported first-quarter 2026 results, with sales rising to US$285.36 million and net income to US$8.52 million, while also assuming operations of three senior living communities across Arizona and Wisconsin totaling 194 units. Together, the stronger earnings and continued expansion of Pennant’s senior living footprint highlight how the company is actively scaling its post-acute care and housing platform. Next, we’ll examine how Pennant’s stronger Q1...
NYSE:LXU
NYSE:LXUChemicals

What LSB Industries (LXU)'s Profit Rebound and Expansion Plans Mean For Shareholders

In late April 2026, LSB Industries, Inc. reported first-quarter sales of US$169.49 million and net income of US$19.69 million, reversing a loss a year earlier. Alongside this earnings improvement, management highlighted active review of debottlenecking projects and potential acquisitions or partnerships to expand fertilizer and industrial production capacity and gain scale. With earnings swinging to profit and management evaluating capacity-expanding investments, we’ll now examine how this...
NYSE:NGVT
NYSE:NGVTChemicals

Should Ingevity’s Divestiture-Driven Earnings and ESOP Shelf Filing Prompt Strategic Reassessment From NGVT Investors?

Ingevity Corporation recently reported past first-quarter 2026 results showing sales of US$258 million, net income of US$59.8 million, and earnings lifted by gains from divesting its Industrial Specialties and Road Markings product lines. The company also filed a US$45.16 million shelf registration for 580,000 common shares tied to its ESOP, highlighting ongoing capital management alongside a pivot toward higher-margin core businesses. Against this backdrop, we will now examine how the...
NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

Does Pool’s (POOL) CEO Transition and Dividend Hike Reveal a Deeper Capital Allocation Shift?

Pool Corporation recently announced that, effective May 4, 2026, John B. Watwood became President and CEO, succeeding Peter D. Arvan, while long-time director John E. Stokely moved into the Executive Chair role and the Board approved a quarterly dividend increase to US$1.30 per share. These leadership changes, alongside the appointment of new director Mark A. Pompa and a higher dividend, signal the Board’s focus on continuity, governance refreshment, and capital returns to...
NYSE:PFE
NYSE:PFEPharmaceuticals

If AI Reshapes Healthcare, These Three Stocks Could Lead

AI in healthcare sits at the crossroads of powerful themes investors are already watching, from inflation and tighter financing conditions to pressure on productivity and public budgets. As energy costs and rates keep policy makers on alert, hospitals, insurers and drug developers are under pressure to do more with less, while patients still want faster, more accurate care. The Transformative AI Healthcare Stocks screener filters for companies using AI to tackle diagnostics, treatment and...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

How Investors May Respond To Atlanta Braves Holdings (BATR.K) Strong Q1 Revenue Amid Continuing Losses

Atlanta Braves Holdings, Inc. has reported past first-quarter 2026 results showing revenue of US$72.01 million versus US$47.21 million a year earlier, with a net loss of US$40.48 million and basic and diluted loss per share of US$0.63. The combination of higher revenue and a slightly narrower loss highlights how the Braves’ media and stadium-driven business model can add scale even while the team remains loss-making. We’ll now examine how this stronger year-over-year revenue performance...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Three High ROE Stocks With Quietly Powerful Balance Sheets

Markets are wrestling with higher inflation, rising bond yields and volatile energy prices, so quality balance sheets matter more than ever. When borrowing costs and policy expectations shift frequently, companies with strong return on equity, resilient past performance and solid finances can give you cleaner exposure to long term growth stories, without relying on heavy leverage or speculative turnarounds. This article focuses on a curated screener that looks exactly for that mix of quality...
NYSE:XPO
NYSE:XPOTransportation

The Bull Case For XPO (XPO) Could Change Following Q1 2026 Earnings Beat And Buyback Completion

XPO, Inc. has already reported its first-quarter 2026 results, with sales of US$2,096 million and net income of US$101 million, alongside completing a US$155 million buyback of 1,114,779 shares announced in March 2025. The combination of stronger earnings, technology-driven efficiency gains in its less-than-truckload operations, and easing fuel costs underlines how XPO is using both operational execution and capital returns to strengthen its freight transportation business. We’ll now examine...
NYSE:INGR
NYSE:INGRFood

Lowered Guidance And Plant Disruptions Could Be A Game Changer For Ingredion (INGR)

In the first quarter of 2026, Ingredion reported lower results year on year, with net sales of US$1,792 million and net income of US$142 million, and cut its full-year 2026 earnings guidance while flagging plant disruptions and the planned closure of its Cabo, Brazil facility. Alongside weaker earnings, the company signaled a shift in its footprint and capital allocation by consolidating Latin American operations and continuing share buybacks, repurchasing 674,911 shares for US$78.42 million...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Why Gibraltar Industries (ROCK) Is Up 6.3% After Reaffirming 2026 Guidance Despite Q1 Net Loss – And What's Next

In early May 2026, Gibraltar Industries reported first-quarter sales of US$356.29 million, up from US$246.36 million a year earlier, but swung from a US$21.12 million profit to a US$67.47 million net loss largely tied to the OmniMax acquisition and discontinued Renewables operations. Despite this loss and margin pressure from commodity inflation and higher interest costs, management reaffirmed full-year 2026 guidance, signaling confidence in OmniMax integration benefits, improving...